[{"NetIncomeLossConverted_3_Q3_USD":-117838000.0,"NetIncomeLossConverted_1_Q3_USD":-41041000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":48595420.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":48417300.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-81561000.0,"CommonStockSharesOutstanding_0_Q3_shares":49208425.0,"StockholdersEquity_0_Q3_USD":466678000.0,"Assets_0_Q3_USD":495275000.0,"CommonStockSharesConverted_0_Q3_shares":49208425.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":48595420.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":48417300.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]